These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26558323)
41. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations. Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694 [TBL] [Abstract][Full Text] [Related]
42. Active state-like conformational elements in the beta2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs. Han DS; Wang SX; Weinstein H Biochemistry; 2008 Jul; 47(28):7317-21. PubMed ID: 18558776 [TBL] [Abstract][Full Text] [Related]
43. β2-adrenoceptor ligand efficacy is tuned by a two-stage interaction with the Gαs C terminus. Kim K; Paulekas S; Sadler F; Gupte TM; Ritt M; Dysthe M; Vaidehi N; Sivaramakrishnan S Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836582 [TBL] [Abstract][Full Text] [Related]
44. Ligand induced change of β2 adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analysis. Bai Q; Pérez-Sánchez H; Zhang Y; Shao Y; Shi D; Liu H; Yao X Phys Chem Chem Phys; 2014 Aug; 16(30):15874-85. PubMed ID: 24962153 [TBL] [Abstract][Full Text] [Related]
45. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899 [TBL] [Abstract][Full Text] [Related]
46. Structures of β Su M; Paknejad N; Zhu L; Wang J; Do HN; Miao Y; Liu W; Hite RK; Huang XY Nat Commun; 2022 Jul; 13(1):4095. PubMed ID: 35835792 [TBL] [Abstract][Full Text] [Related]
47. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist. Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744 [TBL] [Abstract][Full Text] [Related]
48. Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures. Madsen JJ; Ye L; Frimurer TM; Olsen OH Protein Sci; 2022 Nov; 31(11):e4456. PubMed ID: 36134696 [TBL] [Abstract][Full Text] [Related]
49. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. Swaminath G; Xiang Y; Lee TW; Steenhuis J; Parnot C; Kobilka BK J Biol Chem; 2004 Jan; 279(1):686-91. PubMed ID: 14559905 [TBL] [Abstract][Full Text] [Related]
50. Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β Sencanski M; Glisic S; Šnajder M; Veljkovic N; Poklar Ulrih N; Mavri J; Vrecl M Sci Rep; 2019 Nov; 9(1):16555. PubMed ID: 31719570 [TBL] [Abstract][Full Text] [Related]
51. GDP Release from the Open Conformation of Gα Requires Allosteric Signaling from the Agonist-Bound Human β Kumar V; Hoag H; Sader S; Scorese N; Liu H; Wu C J Chem Inf Model; 2020 Aug; 60(8):4064-4075. PubMed ID: 32786510 [TBL] [Abstract][Full Text] [Related]
52. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation. Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155 [TBL] [Abstract][Full Text] [Related]
53. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations. Feng Z; Hou T; Li Y J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225 [TBL] [Abstract][Full Text] [Related]
54. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor. Reiner S; Ambrosio M; Hoffmann C; Lohse MJ J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485 [TBL] [Abstract][Full Text] [Related]
55. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. Yao XJ; Vélez Ruiz G; Whorton MR; Rasmussen SG; DeVree BT; Deupi X; Sunahara RK; Kobilka B Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9501-6. PubMed ID: 19470481 [TBL] [Abstract][Full Text] [Related]
56. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies. Yuzlenko O; Kieć-Kononowicz K J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794 [TBL] [Abstract][Full Text] [Related]
57. Ligand modulation of the conformational dynamics of the A Fernandes DD; Neale C; Gomes GW; Li Y; Malik A; Pandey A; Orazietti AP; Wang X; Ye L; Scott Prosser R; Gradinaru CC Sci Rep; 2021 Mar; 11(1):5910. PubMed ID: 33723285 [TBL] [Abstract][Full Text] [Related]